Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Other Non-Current Liabilities (2012 - 2016)

Soligenix's (SNGX) quarterly Other Non-Current Liabilities came in at $1.3 million in Q3 2016, down 38.08% YoY from $2.1 million in Q4 2015, and up 15.35% on a QoQ basis from $1.1 million in Q2 2016.

Soligenix (SNGX) Other Non-Current Liabilities (2012 - 2016) Analysis & Trends

Soligenix (SNGX) has 5 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q3 2016.

  • Quarterly Other Non-Current Liabilities fell 38.08% year-over-year to $1.3 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $1.3 million (down 38.08% YoY) and the FY2015 annual result came in at $2.4 million, down 35.77% from the prior year.
  • Other Non-Current Liabilities advanced to $1.3 million in Q3 2016, from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $10.0 million in Q3 2013 to a low of $1.1 million in Q2 2016.
  • A 5-year average of $5.0 million and a median of $5.2 million in 2015 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2013 — Other Non-Current Liabilities soared 206.38% — and 2016, when it tumbled 81.48%.
  • Tracing SNGX's Other Non-Current Liabilities over 5 years: stood at $2.7 million in 2012, then soared by 206.38% to $8.2 million in 2013, then plunged by 53.89% to $3.8 million in 2014, then plunged by 35.77% to $2.4 million in 2015, then plunged by 45.57% to $1.3 million in 2016.
  • The last three Other Non-Current Liabilities figures came in at $1.3 million (Q3 2016), $1.1 million (Q2 2016), and $1.7 million (Q1 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Soligenix 6.45 Mn 6.45 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2016 1.32 Mn
Jun 30, 2016 1.15 Mn
Mar 31, 2016 1.67 Mn
Dec 31, 2015 2.43 Mn
Sep 30, 2015 2.14 Mn
Jun 30, 2015 6.20 Mn
Mar 31, 2015 5.15 Mn
Dec 31, 2014 3.79 Mn
Sep 30, 2014 7.43 Mn
Jun 30, 2014 8.77 Mn
Mar 31, 2014 9.52 Mn
Dec 31, 2013 8.22 Mn
Sep 30, 2013 9.98 Mn
Jun 30, 2013 5.18 Mn
Dec 31, 2012 2.68 Mn